Raybow brings client projects from medchem to commercial launch and has developed client NCE’s that are now blockbuster status (USD$1Bill. in prescription sales). We are motivated by creating solutions to solve our client’s chemical development challenges in order to get new small molecule drugs to market successfully.

Raybow has 1,500 employees and multiple locations world wide. Raybow's two process R&D hubs are located in Hangzhou and Taizhou, China. There are two manufacturing sites in Suzhou and Taizhou. In the US, Raybow is located in Brevard, NC. This facility focuses on early stage process research through to Phase II supply under GMP. It also makes niche commercial API’s.

Raybow’s sites (not including the R&D hub in Hangzhou) have passed official audits from the FDA (USA), PMDA (Japan), AIFA (Italy), NMPA (China FDA) and others in recent years. Raybow has applied the concept of green chemical production and manufacturing by introducing an advanced environmental protection treatment system, with a complete set of solutions for the company's waste treatment, implementing green production and recirculation.